157 related articles for article (PubMed ID: 23721166)
1. Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease.
Sekiduka-Kumano T; Kawayama T; Ito K; Shoji Y; Matsunaga K; Okamoto M; Edakuni N; Imaoka H; Uchimura N; Hoshino T
BMC Psychiatry; 2013 May; 13():159. PubMed ID: 23721166
[TBL] [Abstract][Full Text] [Related]
2. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.
Mitani H; Shirayama Y; Yamada T; Kawahara R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):531-4. PubMed ID: 16414168
[TBL] [Abstract][Full Text] [Related]
4. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
[TBL] [Abstract][Full Text] [Related]
5. Effects of monoamine oxidase A inhibition on plasma biogenic amine metabolites in depressed patients.
Markianos M; Alevizos B; Hatzimanolis J; Stefanis C
Psychiatry Res; 1994 Jun; 52(3):259-64. PubMed ID: 7527564
[TBL] [Abstract][Full Text] [Related]
6. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
Janssens J; Atmosoerodjo SD; Vermeiren Y; Absalom AR; den Daas I; De Deyn PP
Neurochem Int; 2019 Sep; 128():154-162. PubMed ID: 31034914
[TBL] [Abstract][Full Text] [Related]
7. Impacts of age on plasma monoamine metabolite concentrations in a large cohort of healthy individuals.
Soda E; Miura I; Hoshino H; Kanno-Nozaki K; Ota T; Oguchi H; Watanabe K; Yang Q; Mashiko H; Niwa S
Psychiatry Res; 2014 Dec; 220(1-2):639-45. PubMed ID: 25200191
[TBL] [Abstract][Full Text] [Related]
8. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
Wolkowitz OM; Doran AR; Breier A; Roy A; Jimerson DC; Sutton ME; Golden RN; Paul SM; Pickar D
Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
[TBL] [Abstract][Full Text] [Related]
9. Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia.
Watanabe K; Miura I; Kanno-Nozaki K; Horikoshi S; Mashiko H; Niwa S; Yabe H
Psychiatry Res; 2015 Dec; 230(2):419-23. PubMed ID: 26416588
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma homovanillic acid in depressed females with melancholia and psychosis.
Devanand DP; Bowers MB; Hoffman FJ; Nelson JC
Psychiatry Res; 1985 May; 15(1):1-4. PubMed ID: 3859880
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
[TBL] [Abstract][Full Text] [Related]
12. Biogenic amine metabolites in delusional (psychotic) depression and melancholia subtypes of major depression.
Lykouras L; Markianos M; Hatzimanolis J; Malliaras D; Stefanis C
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1261-71. PubMed ID: 7532316
[TBL] [Abstract][Full Text] [Related]
13. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
Sheline Y; Bardgett ME; Csernansky JG
J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
[TBL] [Abstract][Full Text] [Related]
14. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP
J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224
[TBL] [Abstract][Full Text] [Related]
15. Biogenic amine metabolites in plasma of drug-naive schizophrenic patients: associations with symptomatology.
Markianos M; Botsis A; Arvanitis Y
Biol Psychiatry; 1992 Aug; 32(3):288-92. PubMed ID: 1384728
[TBL] [Abstract][Full Text] [Related]
16. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations.
Heinz A; Weingartner H; George D; Hommer D; Wolkowitz OM; Linnoila M
Psychiatry Res; 1999 Dec; 89(2):97-106. PubMed ID: 10646828
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical variables in delusional depression.
Lykouras E; Markianos M; Malliaras D; Stefanis C
Am J Psychiatry; 1988 Feb; 145(2):214-7. PubMed ID: 2449085
[TBL] [Abstract][Full Text] [Related]
18. Depressive symptoms, monoamines levels, MAO-B activity and effect of treatment in a subset of depressed individuals from government sector hospital at Karachi.
Zeb F; Naqvi S; Rahman R; Farooq AD
Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1509-1519. PubMed ID: 29044007
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine.
Hatzimanolis J; Lykouras L; Markianos M; Oulis P
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1077-85. PubMed ID: 9829289
[TBL] [Abstract][Full Text] [Related]
20. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]